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1Chapter
Atherosclerosis: A Journey around 
the Terminology
Oladimeji Adebayo and Abiodun Moshood Adeoye
Abstract
The term atherosclerosis underwent a tedious pathway to arrive at its current 
status and interpretation. Furthermore, terms such as atherosclerosis, arterioscle-
rosis and arteriolosclerosis appear similar and are misused interchangeably. This 
chapter highlighted the various terminologies linked with atherosclerosis. This 
chapter highlighted how the terminology of atherosclerosis evolved and, also, 
the various classifications, e.g., atherosclerosis, Monckeberg calcific sclerosis and 
arteriolosclerosis, and gave mention to the differences among them.
Keywords: atherosclerosis, arteriosclerosis, arteriolosclerosis
1. Introduction
The understanding of atherosclerosis evolved uniquely in terms of terminol-
ogy, aetiology, structural features or pathophysiology over the last 300 years [1]. 
Furthermore, the three terms, atherosclerosis, arteriosclerosis and arteriolosclero-
sis, with lethal implications and similar terminologies affecting the arterial vessels, 
however, can easily be confused or just used interchangeably indiscriminately 
[1–5]. There is evidence in the literature that these terms are mistakenly inter-
changed [3, 4, 6]. This confusion was not helped by the key stakeholders like the 
pathologists and clinicians who over the years failed to reach a consensus to delin-
eate them [7].
A remarkable example of such confusion is that emanating from the American 
Heart Association (AHA) who publishes journals titled Arteriosclerosis, Thrombosis, 
and Vascular Biology and Hypertension. While the Arteriosclerosis, Thrombosis, and 
Vascular Biology journal publishes mainly articles related to the experimental, 
clinical and epidemiological facets of atherosclerosis, the Hypertension journal has a 
prominent section on “arteriosclerosis” [6].
Interestingly the confusion around the nomenclature appears to be age-long. 
Hueper, WC’s writing in the Archives of Pathology and Laboratory Medicine in 
1945 titled “Arteriosclerosis” suggests the term atherosclerosis was extensively 
used concerning the pathology related to cholesterol metabolism [8]. Rabson 
a medical doctor while writing a letter to the editor of the American College 
of Clinical Pathology expressed his alarm at the confusion of the degenerative 
disease [8, 9]. This alarm was stemmed from the observation of an article titled 
arteriosclerosis, but the article did not use any of such nomenclature rather than 
atherosclerosis [9].
As recent as 1995, the AHA Report from the Committee on Vascular Lesions of 
the Council Arteriosclerosis interchanged arteriosclerosis and atherosclerosis [11].
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Not that there are no prominent attempts to delineate these terms, especially 
for arteriosclerosis and atherosclerosis. As far back as 1963, George Pickering, one 
of the fathers of modern cardiology, highlighted the similar confusion between 
arteriosclerosis and atherosclerosis in his lecture at The University of Alabama, 
published in the article “Arteriosclerosis and Atherosclerosis: The Need for Clear 
Thinking” which stated the definition in clear terms [6, 7]. He believed the confu-
sion might be as a result of affectation of the arterial system by the two entities 
although they affect different arterial sizes. He, however, delineated them by 
defining atherosclerosis as a complex inflammatory process associated with the pres-
ence of oxidized low-density lipoprotein (LDL) cholesterol in the intima and media 
of the arterial wall and arteriosclerosis as the functional depletion of large artery 
elasticity [6].
Also, notable observation is that arteriosclerosis [10] serves two functions, an 
overarching term for other sub-terms and merely a term that can be inter-used 
with atherosclerosis [2, 11]. Besides, there is poor agreement on the terms related to 
atherosclerosis.
Also, over the years, other terms such as Mönckeberg medial calcific sclerosis 
(MCS) and arteriolosclerosis gained popularity [1]. There was a feeble attempt for 
clear terms and classification as related to atherosclerosis.
The chapter will also highlight recommendations on possible reclassification 
based on gross and histopathologic features, among others. In summary, the chapter 
will extensively discuss the key terms related to arteriosclerosis and the historical 
evolution of these terms and highlight recommendations on possible reclassification 
as having been previously recommended and published.
2. Arteriosclerosis
Arteriosclerosis is derived from the Greek word arteria, meaning artery, and 
sclerosis, meaning hardening, and “osis” is a Greek suffix that means a diseased 
condition [14]. Much literature appears to refer to arteriosclerosis as the overarch-
ing term that includes three different lesions, atherosclerosis, arteriolosclerosis 
and Mönckeberg medial calcific sclerosis (Figure 1) [2, 12]. The three lesions 
are underpinned by the resultant hardening and thickening of the arterial wall 
[2]. However there appears not to be any consensus document by any significant 
cardiovascular or pathology organization on such division rather than such classi-
fication emanated from classic textbooks of pathology [1]. Many articles also carry 
this classification [13].
It, however, appears that the term is also used to describe the functional diminu-
tion of large artery elasticity marked by pulse wave velocity [14]. It, however, brings 
to fore another dimension of intermix with atherosclerosis.
Figure 1. 
The classification of arteriosclerosis.
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3. Atherosclerosis
Atherosclerosis is derived from the Greek word “athero”, meaning gruel or paste, 
and sclerosis, meaning hardening, and “osis” is a Greek suffix that describes a diseased 
condition [15]. It merely is the hardening of an artery precisely due to an atheromatous 
plaque. Atherosclerotic lesions otherwise called atheromata are asymmetric focal 
Year Milestones
1575 Fallopius wrote about “a degeneration of arteries into bone,” and anatomists of that era 
commonly mentioned ossified arteries [2]
1740 Johann Friedrich Crell described this as the hardening of the vessels instead of bony arteries [17]
1755 von Haller described this hardening as thickening as “atheroma” [1, 37, 38]
1833 Frenchman Jean Frederic Martin Lobstein first used the term “arteriosclerosis” to describe 
calcified arterial lesions [1]
1868 George Johnson limited the term arteriosclerosis to “noncalcified, non-atheromatous 
stiffening of small vessels” [2]
1881 Jean Frederic Martin Lobstein first used the term arteriosclerosis in the second volume of his 
book titled Traité d’Anatomie Pathologique [17, 39]
1903 Mönckeberg arteriosclerosis was first described and named after Johann Georg Mönckeberg 
using details from 130 patients. It was also called “Mönckeberg media sclerosis” or 
“Mönckeberg media calcinosis” [38, 40]
1904 Félix Marchand introduced the term “atherosclerosis” and suggested it is responsible for 
obstructive processes in the arteries [2, 33, 41]
1908 A.I. Ignatowski demonstrated that rabbits experimentally develop atherosclerosis by feeding 
on cholesterol-rich food of egg and meat [33, 34]
1910 Adolf Windaus demonstrated that atheromatous plaque has a concentration of cholesterol [33, 42]
1914 Anitschkow described the role of cholesterol accumulation in the development of 
atherosclerosis [35]
2012 Faber differentiated calcification in the coronary arteries which are atherosclerotic in origin 
from Mönckeberg sclerosis [4]
1913 Nikolai N. Anichkov showed that cholesterol alone caused the atheromatous changes in the 
vascular wall [33, 43]
1954 Rabson SM noted that arteriosclerosis lacked specificity, uniformity and consistency. He 
suggested how the term would be used [2]
1961 Sir George Pickering, one of the fathers of modern cardiology in his lecture at the fourth 
Tinsley Randolph Harrison lecture at The University of Alabama, clearly differentiated 
arteriosclerosis and atherosclerosis
1965 Eggen and other workers demonstrated atherosclerotic coronary artery calcification [4]
1971 Russell Ross and Seymour J. Klebanoff using electron microscopy demonstrated that the 
atherosclerosis lesions are characterized by an accumulation of smooth muscle cells associated 
with abundant connective tissue matrix [44]
1972 Ross and colleagues showed that vascular smooth muscle cells proliferate and synthesize and secrete 
all three major constituents of connective tissue: collagen, elastic fibre microfibrils and elastin
1975 Watanabe heritable hyperlipidaemic rabbits were discovered and subsequently used in most 
experimental settings for lipid disorder and atherosclerosis [45]
1985 Brown and Goldstein discovered the role of low-density lipoprotein (LDL) receptors which 
won them the 1985 Nobel Prize
1992 The AHA started to release a series to define the intima of human arteries and its 
atherosclerosis-prone regions
1995 The AHA published the last of report classifying atherosclerosis using histological 
composition and structure [11]
Table 1. 
Key milestone which refined the term atherosclerosis and related terms.
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Atherosclerosis [18] Arteriolosclerosis Mönckeberg arteriosclerosis
Dyslipidaemia Dyslipidaemia
Hypertension Hypertension
Diabetes mellitus Diabetes mellitus Diabetes mellitus
Genetic risk factors Genetic risk factors such as 
ABCC9 gene variant
Genetic diseases such as Keutel 
syndrome
Inflammation Chronic inflammatory disease such 
as systemic lupus erythematosus, etc.
Ageing Ageing Ageing
Disturbances of calcium metabolism
Obesity
Family history of early heart 
disease or coronary heart 
disease
Chronic kidney disease Chronic kidney disease
Smoking and other tobacco use
High level of CRP
Alcohol
Sleep apnoea
Sedentary lifestyle
Fibrinogen level
Type A personality type
Air pollution
Blood-brain barrier 
dysfunctions
Table 2. 
The risk factors associated with atherosclerosis, arteriolosclerosis and Mönckeberg’s arteriosclerosis.
Atherosclerosis Arteriolosclerosis Mönckeberg 
arteriosclerosis
Key processes Lipid accumulation Protein accumulation 
and fibromuscular 
proliferation of the 
intima
Calcium 
deposition
Type of process Pathologic Pathologic Physiology and 
pathologic
Vessels affected Large and medium 
arteries
Concentric media 
thickening of muscular 
arteries
Part of the vessel affected Intima and underlying 
smooth muscle
Media Internal elastic 
lamina
Pathomorphological Plaque-forming 
degenerative changes 
of the large elastic 
arteries such as the 
aorta
Thickening of the vessel 
walls that narrows the 
lumen
Patchy 
calcification of 
the intima
Effect on vessel dimension Decrease Decrease Nil
Calcification ++ +++
Table 3. 
Some key differences in atherosclerosis, arteriolosclerosis and Mönckeberg arteriosclerosis.
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thickenings of the intima which is the innermost layer of the artery [16]. While arte-
riosclerosis is a chronic pathological disease concept which refers to arterial lesions 
characterized by intimal thickening, stiffening and remodelling of the arterial walls [2]. 
Atherosclerosis is a generic term used to describe a general term describing a hardening 
of medium or large arteries [1, 2]. It is also referred to as atherosclerotic vascular disease.
The atheroma principally blocks large- and medium-sized elastic and muscular 
arteries leading to ischemia in the heart, brain or extremities, thereby causing infarction 
[17]. The most critical risk factor for atherosclerosis is dyslipidaemia due to high plasma 
concentrations of cholesterol, especially low-density lipoprotein (LDL) cholesterol or 
high-density lipoprotein. While dyslipidaemia is a key risk factor, it can be found at age 
(Tables 1–3) [17]. The critical step in atherosclerosis formation includes (i) fatty streak 
formation, (ii) atheroma formation and (iii) atherosclerotic plaque formation [18].
4. Arteriolosclerosis
Arteriolosclerosis is simply the hardening and loss of the elasticity of the small 
arteries and arterioles due to the progressive increase in the elastic and muscular 
components of the wall of those vessels. It is simply the small vessel disease and prin-
cipally affects the brain and the kidneys [19, 20]. In the brain, it is associated with 
the lacunar infarcts, vascular cognitive impairment and diffuse white matter lesions 
[19]. The key predisposing factors include hypertension, ageing, ABCC9 gene vari-
ant, diabetes mellitus and blood-brain barrier dysfunctions (Tables 2 and 3) [21]. 
The sub-types include hyaline arteriolosclerosis and hyperplastic arteriolosclerosis.
5. Mönckeberg medial calcific sclerosis (MCS)
Monckeberg medial calcific sclerosis (MCS), Mönckeberg arteriosclerosis, or 
Mönckeberg sclerosis is a degenerative and noninflammatory disease in which the 
media of medium-sized and small muscular arteries becomes calcified independent 
of atherosclerosis [22]. It is also considered as atherosclerotic medial calcification [4]. 
It is a ringlike calcification of the vascular media of small- to medium-sized vessels 
without associated intimal thickening [22, 23]. It is a form of arteriosclerosis or ves-
sel hardening, where calcium deposits are in the muscular middle layer of the walls 
of arteries (the tunica media). It usually causes damage to the kidney and heart.
Mönckeberg arteriosclerosis is commonly mixed up with calciphylaxis and prob-
ably is the most controversial type of arteriosclerosis [4, 24].
6. Historical background of atherosclerosis
Atherosclerosis or other related nomenclatures are not new disease entities 
(Tables 2 and 3). There was, however, some emerging insight into what was later 
termed as atherosclerosis. Hippocrates (469–377 BC), the father of modern medicine, 
described the sudden cardiac death, while approximately 300 BC, Erasistratus 
described the typical claudication intermittent symptoms of peripheral arterial 
disease [25].
Egyptian mummies were noted to have evidence of atherosclerosis; although this 
was not yet named atherosclerosis [8, 26–28]. In the earlier times, due to the lack of 
sophisticated equipment to help the understanding, degenerative and nondegenera-
tive arteriopathy was also lumped together and poorly delineated. However, the 
understanding of atherosclerosis increased exponentially in the last seven decades, 
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even though it was earlier thought to be a mere accomplishment of ageing and 
dodged for many years with controversies surrounding its link with cholesterol [27].
Albrecht von Haller, a Swiss biologist and the father of experimental physiology, 
used the Latin term “atheroma,” in 1755, to describe the plaque deposited on the 
innermost layer of systemic artery walls [29]. However it appears that Celsius may 
have used the same word about 2000 years ago while describing a fatty tumour [30].
In 1575, Fallopius wrote about “a degeneration of arteries into bone” suggestive 
of the presence of calcified atherosclerotic lesions in the arteries. Furthermore, 
ossified arteries were commonly mentioned by anatomists of that era [2]. By the 
eighteenth century, it was apparent that some progress has been made in under-
standing albeit rudimentary on what we call atherosclerosis today. For example, in 
1799, Parry suggested the relationship between coronary lesions and the symptoms 
of angina pectoris [25].
Also, in 1815, J. Hodgson defined the fatty arterial degeneration as atheroma-
tosis [30].
Frenchman Jean Frederic Martin Lobstein first used the term “arteriosclerosis” 
to describe calcified arterial lesions in his main body of work, a four-volume work 
on pathological anatomy written in French titled Traité d’Anatomie Pathologique 
(Treatise on Pathological Anatomy), based upon his vast personal experience [1, 25]. 
The work was unfinished at the time of his death in 1835.
The first mention of nondegenerative arteriopathy in the textbook was 
by Maurice Raynaud’s in De l’Asphyxie Locale et de la Gangrene Symetrique des 
Extremites (1852) and Leo Buerger’s “Thromboangiitis obliterans” [31]. While in 
1879, more than 80 years later, Potain interpreted the relationship Parry found to 
arise from myocardial ischemia [25].
From 1900 onwards, the most significant progress in the understanding of 
atherosclerosis was made. At the beginning of the twentieth century, Aschoff intro-
duced atherosis and atherosclerosis to describe morphologically different intimal 
lipid deposits of children and adults as early and late stages, respectively [32].
By 1904, Félix Marchand suggested that “atherosclerosis” should be better 
instead of “atheroma” as earlier described by Haller [29]. He had combined two 
Greek root words: athéré, which meant gruel or porridge, and sclerosis, which 
signifies hardening [29]. He did not only gave a nomenclature currently in use, 
but he also did justice to the pathologic process involving the association of fatty 
degeneration and vessel stiffening. He believed that atherosclerosis was responsible 
for almost all obstructive processes in the arteries [33]. In 1910, Adolf Windaus 
demonstrated that aortic “atheromatous lesions” contained six times as much as 
free cholesterol and 20-fold of esterified cholesterol compared to normal aortic wall 
[27, 33]. A.I. Ignatowski demonstrated that rabbits experimentally develop athero-
sclerosis by feeding on cholesterol-rich food of egg and meat [33, 34].
In 1914, Anitschkow, influenced by Ignatowski’s work, gave the first descrip-
tion of the role of cholesterol accumulation in the development of atherosclerosis 
while emphasizing the cardinal role of cholesterol in atheromatous changes in the 
vascular wall [35]. He had used a cholesterol-fed rabbit model while working at 
the Military Medical Academy in St. Petersburg to demonstrate that the extent of 
atherosclerosis was proportional to the absolute amount of and length of exposure 
to high blood cholesterol [27, 35]. His discovery was a defining moment in the 
study of this disease entity, although not without scepticism. While the rabbit 
model develops atherosclerosis after being fed high amounts of meat, eggs and 
milk, the dog and rat model did not [33]. This finding by later workers almost 
torpedoed this discovery attributable to Anitschkow [27]. It was also a blow to the 
lipid hypothesis due to these later species relative resistance to diet-induced hyper-
cholesterolemia. Other factors that may have eroded the most unequivocal link of 
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cholesterol and atherosclerosis as enunciated by Anitschkow was the prevailing 
senescence hypothesis as a plausible reason for the development of atherosclerosis 
when he made the discovery [27]. Anitschkow also first described the cholester-
inesterphagozyten, which today commonly is known as foam cells, derived from 
macrophages [25, 35].
The discussion of lipid hypothesis generally in the first 50 years of the twenti-
eth century was also dodged with controversy, particularly the role of high blood 
cholesterol levels to the causal relationship of atherosclerosis and coronary heart 
disease, and that atherosclerosis was a reward of ageing as espoused by senescence 
hypothesis [27, 36].
With the improvement in morphological, immunohistological and molecular 
methods and advanced investigative techniques, LDL receptor and its roles in the 
development of atherosclerosis were discovered by Brown and Goldstein [25]. By 
1958, there was enough information to make classification of atherosclerosis by the 
World Health Organization and described the sequences as a fatty streak, atheroma, 
fibrous plaque and complicated lesions [32]. The American Heart Association 
(AHA) starting from 1992 proposed a new morphological classification based on 
eight lesion types designated by Roman numerals which indicate the usual sequence 
of lesion progression [32].
Jian-Jun Li and Chun-Hong Fang’s writing in Medical Hypotheses journal suggests 
that atheroscleritis is a more rational term for atherosclerosis [29].
We now know the pathological processes that underpin atherosclerosis, which 
entails (1) endothelial injury, (2) intimal cholesterol accumulation and monocyte 
invasion with subsequent foam cell formation, (3) migration and proliferation of 
smooth muscle cells with expression of extracellular matrix, (4) local thrombus 
formation with secondary organization, (5) calcification and/or plaque rupture and 
(6) final occlusion due to plaque rupture/thrombus formation [25].
7. Challenges with terms
Gregory et al. pointed out the difficulty with terms which they notice: (i) it has 
an inconsistent naming convention, (ii) it fails to use terms that accurately describe 
the lesions, (iii) significant sclerotic arterial lesions are absent from the classifica-
tion, and (iv) interchangeability of arteriosclerosis and atherosclerosis [2]:
1. Naming convention. The three authors noticed that the arteriosclerosis, 
atherosclerosis and Mönckeberg medial sclerosis are defined by their gross 
and histopathologic attributes while arteriolosclerosis was defined by vessel 
dimension [2]. Furthermore, “arteriolo” is a descriptive pathologic term.
2. Description of lesion. This term poorly describes the terms [2]. The Möncke-
berg medial sclerosis as described by Mönckeberg, ironically, may not be de-
scribed, and the lesion may involve the arterial intima rather than the arterial 
media [2]. Furthermore, arteriolosclerosis, which is a hardening of the vessel, 
does not describe the lesion since the process involves both protein accumula-
tion and fibromuscular proliferation of the intima [1].
3. Absence of crucial lesion from the classifications. Restenosis lesions after 
balloon angioplasty and stenting, transplant arteriopathy, intimal nonathero-
sclerotic proliferative lesions in arterial vessels larger than arterioles, and a 
variety of disorders associated with vascular calcification are not yet included 
in the current classification.
Atherosclerosis, Arteriosclerosis and Arteriolosclerosis
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Although Gregory et al. highlighted the problems with terms, they retained the 
classifications which do not have all the necessary inclusion [2]. They suggested 
atherosclerosis, primary arterial calcification, fibromuscular intimal hyperplasia, 
hyalinosis, and miscellaneous categories which include amyloidosis and oxalosis, 
among others [1].
8. Conclusion
Atherosclerosis, arteriosclerosis and arteriolosclerosis are not only confused; 
they are also associated with some controversies. However, while the current clas-
sifications and description of terms have been developed over the centuries, there 
are possible better ways to classify the terms.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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